Tim Schlidt

Tim Schlidt is a seasoned professional in the healthcare sector, currently serving as Co-Founder and Partner at Palo Santo since May 2020. Alongside this role, Tim is an active Board Member at Ksana Health and a Board Observer at multiple organizations, including Gilgamesh Pharmaceuticals, Kanna Health, and Bexson Biomedical, as well as serving as an Advisor to Tactogen. Prior experience includes a position as Board Member at Reset Pharmaceuticals and a tenure as a Private Equity Associate at Madison Dearborn Partners, LLC, from July 2017 to August 2019. Tim began their career in finance as an Investment Banking Analyst at Greenhill & Co., focusing on life sciences and healthcare services, and previously interned as a Summer Analyst at J.P. Morgan in healthcare coverage. Tim holds a Bachelor of Business Administration in Finance, Investment & Banking from the University of Wisconsin-Madison.